Multimodal treatment in operable breast cancer: five-year results of the CMF programme. (Q34778895)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6784849%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

title

Multimodal treatment in operable breast cancer: five-year results of the CMF programme (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6784849%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

1 reference

A Rossi

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6784849%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

G Bonadonna

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6784849%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

P Valagussa

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6784849%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

U Veronesi

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6784849%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

language of work or name

English

0 references

publication date

1 May 1981

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6784849%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6784849%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

volume

282

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6784849%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

issue

6274

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6784849%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

page(s)

1427-1431

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6784849%20AND%20SRC:MED&resulttype=core&format=json

Dose-response effect of adjuvant chemotherapy in breast cancer

19 October 2019

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1505178

The evolution of primary multimodality treatment in resectable breast cancer

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1505178

Surgery plus adjuvant chemotherapy--a review of therapeutic implications. I. Breast cancer

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1505178

Response and survival in advanced breast cancer after two non-cross-resistant combinations

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1505178

Combination Chemotherapy as an Adjuvant Treatment in Operable Breast Cancer

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1505178

Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1505178

Combined chemotherapy and surgery in breast cancer: a review

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1505178

Patterns of relapse and survival following radical mastectomy.Analysis of 716 consecutive patients

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1505178

Postoperative Adjuvant Chemotherapy With Fluorouracil, Doxorubicin, Cyclophosphamide, and BCG Vaccine

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1505178

Biological and clinical considerations regarding the use of surgery and chemotherapy in the treatment of primary breast cancer

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1505178

The CMF program for operable breast cancer with positive axillary nodes:Updated analysis on the disease-free interval, site of relapse and drug tolerance

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1505178

Rationale for adjuvant chemotherapy

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1505178

Repeated adjuvant chemotherapy with phenylalanine mustard or 5-fluorouracil, cyclophosphamide, and prednisone with or without radiation, after mastectomy for breast cancer

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1505178

The contribution of recent NSABP clinical trials of primary breast cancer therapy to an understanding of tumor biology--an overview of findings

7 July 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/6784849

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Trials of adjuvant chemotherapy in breast cancer. The experience of the Istituto Nazionale Tumori of Milan

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/6784849

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1136/BMJ.282.6274.1427

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6784849%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6784849%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

PubMed publication ID

6784849

1 reference